LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

Search

Perspective Therapeutics Inc

Затворен

5.65 12.55

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

4.96

Максимум

5.65

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+154.87% upside

Дивиденти

By Dow Jones

Следващи печалби

26.03.2026 г.

Perspective Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.02.2026 г., 22:31 ч. UTC

Печалби

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18.02.2026 г., 22:18 ч. UTC

Печалби

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18.02.2026 г., 22:11 ч. UTC

Печалби

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18.02.2026 г., 21:52 ч. UTC

Печалби

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18.02.2026 г., 23:56 ч. UTC

Пазарно говорене

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18.02.2026 г., 23:46 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

18.02.2026 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18.02.2026 г., 23:34 ч. UTC

Пазарно говорене
Печалби

Brambles' Cost Control Stands Out to Bull -- Market Talk

18.02.2026 г., 23:33 ч. UTC

Пазарно говорене

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18.02.2026 г., 23:32 ч. UTC

Пазарно говорене

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18.02.2026 г., 22:45 ч. UTC

Печалби

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18.02.2026 г., 22:44 ч. UTC

Пазарно говорене

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18.02.2026 г., 22:37 ч. UTC

Печалби

Nutrien 4Q EPS $1.18 >NTR.T

18.02.2026 г., 22:37 ч. UTC

Печалби

Nutrien 4Q Sales $5.34B >NTR.T

18.02.2026 г., 22:35 ч. UTC

Печалби

Pan American Silver 4Q EPS $1.07 >PAAS

18.02.2026 г., 22:35 ч. UTC

Печалби

Pan American Silver 4Q Rev $1.18B >PAAS

18.02.2026 г., 22:30 ч. UTC

Печалби

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18.02.2026 г., 22:29 ч. UTC

Печалби

Kinross Gold 4Q EPS 75c >K.T

18.02.2026 г., 22:22 ч. UTC

Печалби

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18.02.2026 г., 22:22 ч. UTC

Пазарно говорене

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18.02.2026 г., 22:16 ч. UTC

Печалби

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18.02.2026 г., 22:05 ч. UTC

Печалби

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18.02.2026 г., 22:03 ч. UTC

Печалби

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18.02.2026 г., 22:02 ч. UTC

Печалби

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18.02.2026 г., 22:02 ч. UTC

Печалби

Kaiser Aluminum 4Q Sales $929M >KALU

18.02.2026 г., 22:02 ч. UTC

Печалби

Kaiser Aluminum 4Q EPS $1.68 >KALU

18.02.2026 г., 22:00 ч. UTC

Печалби

Kinross Gold 4Q Adj EPS 67c >KGC

18.02.2026 г., 22:00 ч. UTC

Печалби

Kinross Gold 4Q Sales $2.02B >KGC

18.02.2026 г., 21:56 ч. UTC

Печалби

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Perspective Therapeutics Inc Прогноза

Ценова цел

By TipRanks

154.87% нагоре

12-месечна прогноза

Среден 12.82 USD  154.87%

Висок 18 USD

Нисък 4 USD

Според 13 анализатори от Wall Street, предложили 12-месечна ценова цел за Perspective Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

13 ratings

12

Купи

1

Задържане

0

Продай

Финанси

$

help-icon Live chat